HER2 receptor conversion is a strong survival predictor in patients with breast cancer brain metastases.
Hormone and HER2/neu receptor status is prognostic and predictive in breast cancer (BC) and guides the choice of therapy. Due to receptor conversion, receptor conversion may differ in metast...